Moderna vaccine gets emergency use approval in India
Govt examining indemnity request by the US vaccine maker : Dr. V.K. Paul
New Delhi: The Drug Controller General of India (DCGI) has granted CIPLA to import Moderna’s COVID-19 vaccine for emergency use. This is the first internationally developed vaccine to be available in India.
“A new drug permission has been granted to Moderna, the first internationally developed vaccine. This new drug permission is for restricted use (or emergency use) . With this, there are four vaccines now Covaxin, Covishield, SputnikV and Moderna. We will soon close the deal on Pfizer as well” Dr. VK Paul, Member-Health, Niti Aayog
He also added that, the government of India is also examining the indemnity request by US based company.
On Pfizer vaccine, he said that the government has multiple rounds of meetings with the US Company. An intensive meeting was held last week and the government is waiting for their response.